Basit öğe kaydını göster

dc.contributor.authorElbuken, Gulsah
dc.contributor.authorKelestimur, Fahrettin
dc.contributor.authorDurcan, Emre
dc.contributor.authorDokmetas, Hatice Sebile
dc.contributor.authorZUHUR, SAYİD SHAFİ
dc.contributor.authorSahin, Serdar
dc.contributor.authorGÜNDOĞDU, AYCAN
dc.contributor.authorNALBANTOĞLU, ÖZKAN UFUK
dc.contributor.authorKADIOĞLU, PINAR
dc.contributor.authorÖZDAMAR KARACA, ZÜLEYHA CİHAN
dc.contributor.authorHACIOĞLU, AYŞA
dc.contributor.authorURHAN, MUHAMMED EMRE
dc.contributor.authorÜNLÜHİZARCI, KÜRŞAD
dc.contributor.authorDEMİR, Ahmet Numan
dc.contributor.authorHora, Mehmet
dc.date.accessioned2022-07-04T14:31:48Z
dc.date.available2022-07-04T14:31:48Z
dc.identifier.citationSahin S., GÜNDOĞDU A., NALBANTOĞLU Ö. U. , KADIOĞLU P., ÖZDAMAR KARACA Z. C. , HACIOĞLU A., URHAN M. E. , ÜNLÜHİZARCI K., DEMİR A. N. , Hora M., et al., "Acromegaly is associated with a distinct oral and gut microbiota", PITUITARY, 2022
dc.identifier.issn1386-341X
dc.identifier.othervv_1032021
dc.identifier.otherav_7e7745c8-44ae-4544-976d-06693deafc73
dc.identifier.urihttp://hdl.handle.net/20.500.12627/183452
dc.identifier.urihttps://doi.org/10.1007/s11102-022-01223-1
dc.description.abstractPurpose Our aim was to investigate the changes in the composition of oral and gut microbiota in patients with newly diagnosed acromegaly and their relationship with IGF-1 levels. Methods Oral and fecal samples were collected from patients with newly diagnosed acromegaly without comorbidities and from healthy controls. The composition of the microbiota was analyzed. The general characteristics, oral and stool samples of the patients and healthy control subjects were compared. The changes in microbiota composition in both habitats, their correlations and associations with IGF-1 were statistically observed using machine learning models. Results Fifteen patients with newly diagnosed acromegaly without comorbidities and 15 healthy controls were included in the study. There was good agreement between fecal and oral microbiota in patients with acromegaly (p = 0.03). Oral microbiota diversity was significantly increased in patients with acromegaly (p < 0.01). In the fecal microbiota, the Firmicutes/Bacteroidetes ratio was lower in patients with acromegaly than in healthy controls (p = 0.011). Application of the transfer learned model to the pattern of microbiota allowed us to identify the patients with acromegaly with perfect accuracy. Conclusions Patients with acromegaly have their own oral and gut microbiota even if they do not have acromegaly-related complications. Moreover, the excess IGF-1 levels could be correctly predicted based on the pattern of the microbiome.
dc.language.isoeng
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectEndocrinology
dc.subjectEndocrine and Autonomic Systems
dc.subjectEndocrinology, Diabetes and Metabolism
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleAcromegaly is associated with a distinct oral and gut microbiota
dc.typeMakale
dc.relation.journalPITUITARY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.contributor.firstauthorID3417051


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster